COMP <GO>
TRUP vs ABBV // EV/EBITDA & P/E VALUATION
Trupanion Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: TRUP 5
— ABBV 8
▲ EV/EBITDA & P/E VALUATION LEADER: ABBV
LAST: $30.19 (+2.27%) • MKT CAP: $1.32B
valuation
49.8x
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
valuation
33.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TRUP VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TRUP | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 16.10% | 70.20% | -54.10 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.10% | 29.00% | -25.90 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 49.8x | 33.3x | +16.50 | ABBV | /valuation <GO> |
| Free Cash Flow Yield | 5.69% | 3.47% | +2.22 | TRUP | /fcf-yield <GO> |
| Operating Margin | 1.00% | 24.60% | -23.60 | ABBV | /operating-margins <GO> |
| Net Profit Margin | 1.40% | 6.90% | -5.50 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 11.90% | 8.60% | +3.30 | TRUP | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.17 | 5.33 | -2.16 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | TRUP | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.4 | 65.1 | +2.31 | TRUP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 63.4x | 113.1x | -49.70 | TRUP | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.32B | $513.86B | -$512.54B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TRUP REV | ABBV REV | TRUP GROSS % | ABBV GROSS % | TRUP FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.44B | $61.16B | 16.1% | 70.2% | $75.4M | $17.82B |
| FY 2024 | $1.29B | $56.33B | 13.9% | 70.0% | $38.6M | $17.83B |
| FY 2023 | $1.11B | $54.32B | — | — | $18.6M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TRUP // BETA —
ABBV // BETA 1.15